Inhaled nebulized glatiramer acetate against Gram-negative bacteria is not associated with adverse pulmonary reactions in healthy, young adult female pigs.
The developmental speed of new antimicrobials does not meet the emergence of multidrug-resistant bacteria sufficiently. A potential shortcut is assessing the antimicrobial activity of already approved drugs. Intrudingly, the antibacterial action of glatiramer acetate (GA) has recently been discovere...
Main Authors: | Sandra M Skovdal, Stig Hill Christiansen, Karen Singers Johansen, Ole Viborg, Niels Henrik Bruun, Søren Jensen-Fangel, Ida Elisabeth Holm, Thomas Vorup-Jensen, Eskild Petersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223647 |
Similar Items
-
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
by: Thomas Vorup-Jensen, et al.
Published: (2012-11-01) -
Inhalers and nebulizers: basic principles and preliminary measurements
by: Misik Ondrej, et al.
Published: (2018-01-01) -
Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension
by: Heidi M. Mansour
Published: (2018-10-01) -
Inhalational injury management: From intubation to nebulized heparin
by: Nissar Shaikh, et al.
Published: (2020-01-01) -
Comparative studies on nebulizers for antigen inhalation in experimental asthma
by: Takeshi Nabe, et al.
Published: (1997-01-01)